Today: 29 April 2026
Browse Category

NSE:NATCOPHARM 1 December 2025 - 8 December 2025

Natco Pharma Share Price Today (8 December 2025): Q2 Results, Adcock Ingram Deal and 2026 Stock Outlook

Natco Pharma Share Price Today (8 December 2025): Q2 Results, Adcock Ingram Deal and 2026 Stock Outlook

Natco Pharma shares fell nearly 3% to around ₹908 on 8 December 2025, despite the company completing a major acquisition in South Africa. The stock remains about 40% below its 52-week high, with year-to-date losses near 33%. Q2 FY26 revenue stood at ₹1,363 crore, almost unchanged from last year. Investors are weighing the drop in Revlimid earnings, higher R&D costs, and the ₹2,000-crore Adcock Ingram deal.
8 December 2025
·
Natco Pharma Share Price Today (2 December 2025): Rating Reaffirmed, USFDA Update, South Africa Deal and 2026 Stock Forecast

Natco Pharma Share Price Today (2 December 2025): Rating Reaffirmed, USFDA Update, South Africa Deal and 2026 Stock Forecast

Natco Pharma shares traded at ₹933–₹936 on 2 December, up 3–3.5% but still down 34% over the past year. Q2 FY26 profit after tax reached ₹517.9 crore on revenue of ₹1,463 crore, with an EBITDA margin near 46%. Management warned the Revlimid windfall is fading, signaling lower profitability ahead. Trading volumes remain high as the stock rebounds from earlier losses.
2 December 2025
·
Natco Pharma Share Price Today (1 December 2025): Q2 Results, USFDA Update, Adcock Ingram Deal & 2026 Forecast

Natco Pharma Share Price Today (1 December 2025): Q2 Results, USFDA Update, Adcock Ingram Deal & 2026 Forecast

Natco Pharma shares jumped nearly 5% to around ₹921 on the NSE by 11:05 am IST Friday, with volumes nearing 2.95 million. The rally follows Q2 FY26 results showing flat revenue at ₹1,363 crore and a 23% drop in net profit to ₹517.9 crore, as Revlimid profits fade and costs rise. Management expects little Revlimid contribution from Q3 onward but has kept full-year PAT guidance at ₹13 billion.
1 December 2025
··

Stock Market Today

  • 3 Undervalued FTSE 100 Shares to Watch Heading Into May 2026
    April 29, 2026, 12:57 PM EDT. FTSE 100 has climbed 3% year-to-date despite geopolitical and economic risks. Among its members, three shares appear undervalued heading into May. Associated British Foods (ABF) trades at a price-to-earnings (P/E) ratio of 14 with a 3.6% dividend yield, despite inflation pressures and Primark demerger plans potentially unlocking value. Reckitt Benckiser (RKT), down 25% year-to-date, holds a P/E of 10 and offers a 4.6% yield amid legal and market challenges, but its strong brands and product categories suggest long-term value. Lastly, WPP's stock has fallen over 21% this year after poor performance last year, showing the highest risk with potential for reward. Investors eye these blue-chips for their divergent recoveries and prospects.

Latest article

Silicon Motion Stock Jumps After Q1 Sales Double and AI Storage Outlook Tops Estimates

Silicon Motion Stock Jumps After Q1 Sales Double and AI Storage Outlook Tops Estimates

29 April 2026
Silicon Motion reported first-quarter revenue of $342.1 million, up 105% from a year earlier, and forecast second-quarter sales above Wall Street estimates. Shares rose $45.09 to $194.27 in New York trading. The company cited strong demand for embedded storage controllers and AI-related enterprise storage. CEO Wallace Kou said its MonTitan SSD controller platform will enter volume production this quarter.
Starbucks Stock Surges After Earnings Beat Makes Niccol’s Turnaround Look Real

Starbucks Stock Surges After Earnings Beat Makes Niccol’s Turnaround Look Real

29 April 2026
Starbucks raised its fiscal 2026 outlook after global comparable store sales rose 6.2% in the second quarter, beating analyst estimates. Shares jumped about 10% to $107.03. North American operating margin fell to 9.9% from 11.6% due to higher labor and product costs. The company now expects at least 5% comparable sales growth for the year.
Teradyne Stock Slides After Record AI Quarter. The Guidance Is Why.

Teradyne Stock Slides After Record AI Quarter. The Guidance Is Why.

29 April 2026
Teradyne shares fell 16% to $319.10 Wednesday after the chip-testing company forecast lower second-quarter revenue and profit, despite posting record first-quarter sales of $1.282 billion, up 87% from a year earlier. About 70% of revenue came from AI-related demand, but management warned of “lumpy growth” due to large customer programs.
Go toTop